Tetra Discovery: Grand Rapids' Tetra Therapeutics Expands Alliance with Japan's Shionogi to Develop Treatment for Cognitive Impairment

Tetra Therapeutics in Grand Rapids, a clinical stage biopharmaceutical company that develops treatments for patients with cognitive impairment and memory loss, has entered into an expanded alliance with Japan's Shionogi, a pharmaceutical provider. Under the terms of the alliance, Shionogi has increased its equity investment in the company to 50 percent and has the option [...]The post Grand Rapids' Tetra Therapeutics Expands Alliance with Japan's Shionogi to Develop Treatment for Cognitive Impairment appeared first on DBusiness Magazine.